Logo image of ARCH.CA

ARCH BIOPARTNERS INC (ARCH.CA) Stock Analyst Ratings

Canada - TSX-V:ARCH - CA03938C1041 - Common Stock

1.06 CAD
+0.03 (+2.91%)
Last: 11/5/2025, 7:00:00 PM
Buy % Consensus

46

ChartMill assigns a Buy % Consensus number of 46% to ARCH.CA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.57. This target is 236.79% above the current price.
ARCH.CA was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about ARCH.CA.
In the previous month the buy percentage consensus was at a similar level.
ARCH.CA was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

ARCH.CA Historical Analyst RatingsARCH.CA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -31 -28 -25 -22 -19 -16 -13 -10 -7 -4 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 1.063.543.573.573.68 - 233.49% 236.79% 236.79% 246.70%

Related screens

ARCH.CA Current Analyst RatingARCH.CA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

ARCH BIOPARTNERS INC / ARCH.CA FAQ

What is the price target for ARCH stock?

7 analysts have analysed ARCH.CA and the average price target is 3.57 CAD. This implies a price increase of 236.79% is expected in the next year compared to the current price of 1.06.


Can you provide the consensus rating for ARCH BIOPARTNERS INC stock?

The consensus rating for ARCH BIOPARTNERS INC (ARCH.CA) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.